Disparities in vaccination rates in solid organ transplant patients.

Jamie R Felzer, Lila J Finney Rutten, Chung-Il Wi, Allison M LeMahieu, Elena Beam, Young J Juhn, Robert M Jacobson, Cassie C Kennedy
Author Information
  1. Jamie R Felzer: Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. ORCID
  2. Lila J Finney Rutten: Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  3. Chung-Il Wi: Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  4. Allison M LeMahieu: Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  5. Elena Beam: Division of Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. ORCID
  6. Young J Juhn: Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  7. Robert M Jacobson: Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  8. Cassie C Kennedy: Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Abstract

INTRODUCTION: Vaccinations against preventable respiratory infections such as Streptococcus pneumoniae and influenza are important in immunosuppressed solid organ transplant (SOT) recipients. Little is known about the role of age, race, ethnicity, sex, and sociodemographic factors including rurality, or socioeconomic status (SES) associated with vaccine uptake in this population.
METHODS: We conducted a population-based study using the Rochester Epidemiology Project, a medical records linkage system, to assess socioeconomic and demographic factors associated with influenza and pneumococcal vaccination rates among adult recipients of solid organ transplantation (aged 19-64 years) living in four counties in southeastern Minnesota. Vaccination data were obtained from the Minnesota Immunization Information Connection from June 1, 2010 to June 30, 2020. Vaccination rate was assessed with Poisson and logistic regression models.
RESULTS: A total of 468 SOT recipients were identified with an overall vaccination rate of 57%-63% for influenza and 56% for pneumococcal vaccines. As expected, vaccination for pneumococcal vaccine positively correlated with influenza vaccination. Rural patients had decreased vaccination in both compared to urban patients, even after adjusting for age, sex, race, ethnicity, and SES. Although the population was mostly White and non-Hispanic, neither vaccination differed by race or ethnicity, but influenza vaccination did by SES. Among organ transplant groups, liver and lung recipients were least vaccinated for influenza, and heart recipients were least up-to-date on pneumococcal vaccines.
CONCLUSIONS: Rates of vaccination were below national goals. Rurality was associated with undervaccination. Further investigation is needed to understand and address barriers to vaccination among transplant recipients.

Keywords

References

  1. Postgrad Med. 2012 May;124(3):71-9 [PMID: 22691901]
  2. Int J Epidemiol. 2018 Apr 1;47(2):368-368j [PMID: 29346555]
  3. Public Health Nurs. 2016 Jul;33(4):277-82 [PMID: 27103181]
  4. Vaccine. 2020 Jan 16;38(3):482-488 [PMID: 31718899]
  5. MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):822-5 [PMID: 25233284]
  6. MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):109-117 [PMID: 35085226]
  7. MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1069-1075 [PMID: 31751323]
  8. Am J Infect Control. 2014 May;42(5):500-5 [PMID: 24630702]
  9. Influenza Other Respir Viruses. 2014 May;8(3):274-81 [PMID: 24382111]
  10. Ann Transplant. 2016 Apr 07;21:200-7 [PMID: 27052410]
  11. Am J Public Health. 2022 Feb;112(2):304-307 [PMID: 35080958]
  12. Transpl Infect Dis. 2016 Feb;18(1):155-9 [PMID: 26461052]
  13. Am J Epidemiol. 2011 May 1;173(9):1059-68 [PMID: 21430193]
  14. MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816-9 [PMID: 23051612]
  15. J Urban Health. 2014 Apr;91(2):272-92 [PMID: 24366854]
  16. MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6 [PMID: 20814406]
  17. Mayo Clin Proc. 2012 Dec;87(12):1202-13 [PMID: 23199802]
  18. Transpl Infect Dis. 2021 Oct;23(5):e13722 [PMID: 34496115]
  19. Am J Transplant. 2021 Feb;21 Suppl 2:356-440 [PMID: 33595196]
  20. Mayo Clin Proc. 2020 Jan;95(1):169-183 [PMID: 31902413]
  21. Vaccine. 2022 Mar 8;40(11):1643-1654 [PMID: 33933316]
  22. Vaccine. 2014 Aug 20;32(37):4766-71 [PMID: 25024111]
  23. Clin J Am Soc Nephrol. 2018 May 7;13(5):755-762 [PMID: 29622669]
  24. J Manag Care Spec Pharm. 2022 Feb;28(2):196-205 [PMID: 35098752]
  25. Am J Med. 2016 Jun;129(6):636.e1-636.e11 [PMID: 26551981]
  26. BMC Public Health. 2016 Sep 21;16(1):1000 [PMID: 27655468]
  27. Transpl Infect Dis. 2021 Aug;23(4):e13607 [PMID: 33773002]
  28. MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62 [PMID: 20689501]
  29. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211040746 [PMID: 34427126]
  30. Hum Vaccin Immunother. 2019;15(4):841-849 [PMID: 30676236]
  31. Clin Transplant. 2019 Sep;33(9):e13563 [PMID: 31002409]
  32. JAMA. 2020 Sep 15;324(11):1029-1030 [PMID: 32930764]
  33. J Urban Health. 2011 Oct;88(5):933-44 [PMID: 21499815]
  34. Epidemiol Infect. 2013 Apr;141(4):880-7 [PMID: 22874665]
  35. Transplantation. 2020 Nov;104(11):2383-2392 [PMID: 31985729]
  36. Vaccine. 2017 Oct 13;35(43):5890-5896 [PMID: 28890192]
  37. Am J Health Promot. 2021 Sep;35(7):908-916 [PMID: 33657844]
  38. Int J Epidemiol. 2012 Dec;41(6):1614-24 [PMID: 23159830]
  39. Vaccine. 2017 Jan 3;35(1):101-108 [PMID: 27890398]
  40. Vaccine. 2020 Sep 3;38(39):6112-6119 [PMID: 32713679]
  41. Hum Vaccin Immunother. 2019;15(4):863-872 [PMID: 30633706]
  42. Am J Transplant. 2021 Feb;21 Suppl 2:21-137 [PMID: 33595191]
  43. Vaccine. 2015 Jun 4;33(24):2741-56 [PMID: 25936726]
  44. Clin Infect Dis. 2014 Feb;58(3):309-18 [PMID: 24421306]
  45. Am J Prev Med. 2021 Oct;61(4):465-473 [PMID: 34334289]
  46. Vaccine. 2021 Apr 1;39(14):1951-1962 [PMID: 33712349]
  47. Ann Fam Med. 2012 Nov-Dec;10(6):538-46 [PMID: 23149531]
  48. Mayo Clin Proc. 2015 Nov;90(11):1562-8 [PMID: 26541249]
  49. Clin Infect Dis. 2018 Oct 15;67(9):1322-1329 [PMID: 29635437]

Grants

  1. /Mayo Clinic Research Committee
  2. AG 058738/NIA NIH HHS
  3. R33 AG058738/NIA NIH HHS
  4. R21 AG058738/NIA NIH HHS
  5. R01 CA217889/NCI NIH HHS

MeSH Term

Adult
Humans
Influenza, Human
Organ Transplantation
Influenza Vaccines
Vaccination
Pneumococcal Vaccines

Chemicals

Influenza Vaccines
Pneumococcal Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccinationinfluenzarecipientsorgantransplantpneumococcalsolidraceethnicitySESassociatedvaccinespatientsSOTagesexfactorssocioeconomicvaccinepopulationratesamongMinnesotaVaccinationJunerateleastINTRODUCTION:VaccinationspreventablerespiratoryinfectionsStreptococcuspneumoniaeimportantimmunosuppressedLittleknownrolesociodemographicincludingruralitystatusuptakeMETHODS:conductedpopulation-basedstudyusingRochesterEpidemiologyProjectmedicalrecordslinkagesystemassessdemographicadulttransplantationaged19-64yearslivingfourcountiessoutheasterndataobtainedImmunizationInformationConnection12010302020assessedPoissonlogisticregressionmodelsRESULTS:total468identifiedoverall57%-63%56%expectedpositivelycorrelatedRuraldecreasedcomparedurbanevenadjustingAlthoughmostlyWhitenon-HispanicneitherdifferedAmonggroupsliverlungvaccinatedheartup-to-dateCONCLUSIONS:RatesnationalgoalsRuralityundervaccinationinvestigationneededunderstandaddressbarriersDisparitiesflugeographicdisparities

Similar Articles

Cited By (3)